EUSTM 2016 – SCIENTIFIC AGENDA

Pre Congress Day: Sunday, 16 October 2016

15:00- 18:30 Workshop : Publications (Research Articles) Writing Skills

DAY 1  : Monday, 17 October 2016

8:30 Conference Registration
10:00

Welcome Remarks

Aamir Shahzad
President,
European Society for Translational Medicine, Vienna, Austria 

Ulrich Pfeffer
Secretary G, European Society for Translational Medicine, Genova, Italy

10:15 Admission Ceremony (ATMP Academy)

Academy Fellowships: FAcadTM

Moderator: Antonio Facchiano

11:00 Keynote Talk

Pro-angiogenic features of Natural Killer cells in cancer patients; potential for diagnostic and therapeutic approaches

Douglas M Noonan
Department of Biotechnology and Life Sciences, University of Insubria, Insubria, Italy

12:00 Lunch I Poster Viewing
13:00 Scientific Session C

New Horizons in Biomarkers & Diagnostics

A systematic review of the diagnostic and prognostic value of urinary protein biomarkers in urothelial bladder cancer

Richard Bryan
University of Birmingham,  Birmingham, UK

Novel tools in diagnosing inherited metabolic diseases

Tomáš Adam
Institute of Molecular and Translational Medicine, Palacký University Hospital, Olomouc, Czech Republic

Take my breath away: non-invasive breathomics for bacterial detection

Roy Goodacre
School of Chemistry The University of Manchester, Manchester, UK

Chair: Roy Goodacre
14:00 Scientific Session C:

Latest Developments & Updates in Cellular & Molecular Biology

No in-vivo constriction of the fetal ductus arteriosus by a prostanoid PGF2α-receptor antagonist in rats

Oliver Pohl
ObsEva SA, Plan-les-Ouates, Geneva, Switzerland

Detection of S-(2-succinyl)cystein (2SC) in peripheral blood by LC-MS/MS as a marker for mitochondrial dysfunctions

Ryoji Nagai
Tokai University, Kumamoto, Japan

Reducing non-specificity and enhancing functionality of TCR gene modified T cells by preventing mis-pairing

Shao-An Xue
University College London Medical School, London, UK

Chair: Shao-An Xue
15:00 Scientific Session E:

Novel Findings and Updates in Translational Oncology

A novel strategy to modulate tumor energy metabolism

Lizzia Raffaghello
Laboratories of Oncology, G. Gaslini Institute, Genoa, Italy

Decorin in human epithelial cancers

Annele Sainio
University of Turku, Turku, Finland

Loss of Smad4 in colorectal cancer induces metastasis and resistance to 5-fluorouracil

Pran Datta
The University of Alabama at Birmingham, Birmingham, AL, USA

Chair: Pran Datta
16:00 Coffee Break I Poster Viewing
16:30 Scientific Session E:

Novel Findings and Updates in Regenerative Medicine

The cardioprotective potential of the human amniotic fluid stem cell secretome in a doxorubicin-derived cardiotoxicity model

Sveva Bollini
Department of Experimental Medicine (DIMES), University of Genoa, National Institute for Cancer Research, Genoa, Italy

Integrating metabolomics with single cell analysis for the investigation of mammalian cell systems

Katherine Hollywood
University of Manchester, Manchester, UK

Recovery and expansion of normal human neural progenitor (stem) cells after 12 years of cryo-preservation: The next evolution in regenerative medicine?

Thomas Goodwin
Ex. Biomedical Research and Environmental Sciences Division, NASA, Houston, USA

Chair: Thomas Goodwin
17:30 Scientific Session E:

New Developments & Updates in Precision Medicine

The translation-standardisation paradox: Translational strategies to tackle it

Frans Stafleu
Ethics Institute Utrecht University, Utrecht, Netherlands

Precision Medicine in Sepsis: hype or hope?

Enitan D Carrol
Department of Clinical Infection  Microbiology and Immunology,  University of Liverpool, Liverpool, UK

Individual Metabolite Trajectories & Personalized Countermeasures in Elite Athletes

Michael A.  Schmidt
Research Innovation Center Colorado State University, Fort Collins, USA

Chair: Michael A. Schmidt
18:30 Day End
 18:30 Editorial Board Meeting:

New Horizons in Translational Medicine & New Horizons in Clinical Case Reports Journals  (Only open for EB Members )

DAY 2 : Tuesday, 18 October 2016

8:00 Conference Registration
9:30

Scientific Session C:

Latest Developments & Updates in Cellular & Molecular Biology

Altered expression of IFN-λ2 in allergic airway disorders and identification of its cell origins.

Shaoheng He
The First Affiliated Hospital,  Liaoning Medical University, Jinzhou, China

Recombinant lipidated dengue envelope protein domain IIIs induces functional immunity against all four serotypes of dengue virus

Hsin-Wei Chen
National Health Research Institutes, Miaoli, Taiwan

Involvement of toll-like receptors 7 and 9 in the pathogenesis of inflammatory autoimmune arthritis

Guenter Steiner
Medical University Vienna, Vienna, Austria

Chair: Guenter Steiner
10:30 Coffee Break
11:00 Scientific Session D:

Poster Viewing

12:00 Lunch
13:00 Scientific Session:

Translational Medicine approaches in Drug Discovery & Development

Cell biologic characterization and genomic mechanisms of the histopathologic features of tumors: an issue in translational biomedical science

 Leon Bignold
University of Adelaide, Adelaide, SA, Australia.

Reinstalling immune regulatory tryptophan catabolism in juvenile diabetes via interleukin 6 receptor blockade

Ciriana Orabona
University of Perugia, Dept. Experimental Medicine, Perugia, Italy

The vegf-mimetic peptide qk reduces brain damage induced in rat by middle cerebral artery occlusion without promoting brain edema formation

Mauro Cataldi
Federico II University of Naples, Naples, Italy

Chair: Mauro Cataldi
14:00 Scientific Session B:

Translational Medicine approaches in Drug Discovery & Development

In-silico identification of new therapeutic targets using a molecular signature of an immunosuppressive antibody

Jana Sponarova
Nebion AG, Switzerland

Systematic analysis of liver cancer metabolism – lessons from mice and humans

Stefan  Kempa
Berlin Institute of Health. BIH Core Facility Metabolomics, Max Delbrück Center for Molecular Medicine (MDC), Berlin, Germany

A multi-omics approach to identify new molecular targets in melanoma

Antonio Facchiano
Istituto Dermopatico dell’Immacolata, IDI-IRCCS, Rome, Italy

Chair: Antonio Facchiano
15:00 Coffee Break I Poster Viewing
15:30 Scientific Session C:

New Developments in Preventive Oncology Medicine

Local immunity changes correlate with alterations of collagen architecture in the colon mucosa: a possible new indicator of precancerous conditions

Luca Vannucci
Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic

Cancer chemo-prevention and angio-prevention with diet-derived molecules

Adriana Albini
Vascular Biology and Angiogenesis Laboratory, Ircss MultiMedica, Milano, Italy

Chair: Adriana Albini
16:30 Session D:

Networking Session

17:30 Day End
19:30 Gala Dinner (Extra Registration required)

DAY 3 : Wednesday, 19 October 2016

8:30 Conference Registration
9:30 Scientific Session A:

Latest developments & Updates in Molecular Medicine

Thermoresponsive Chitosan-based Hydrogels Containing Ferulic Acid for Suppression of Oxidative Stress Injury in Cisd2-deficient Cardiomyocytes

Yung-Hsin Cheng
Department of Education and Research, Taipei City Hospital, Taipei, Taiwan

Expression patterns of circulating miR-21, miR-34a, miR-122 and miR125b in patients with chronic hepatitis B virus infection

Michael Baclig
Research and Biotechnology, St. Luke’s Medical Center, Quezon City, Philippines

Understanding Nrf2, guardian of lifespan – a systemic metabolomics study

Drupad K Trivedi
Manchester Institute of Biotechnology, Manchester, UK

Chair: Gottfried Koehler
10:30 Coffee Break I Poster Viewing
11:00 Scientific Session B:

Podium Presentations

Sample size estimation for animal experiments: some approaches to overcome the challenges

Benjamin Mayer
Ulm University, Germany

Antiviral Properties for Natural Extract Artocarpus communis Against Dengue Virus

Tsabita Annisa Muhartono
University of Indonesia, Indonesia

Treatment of head and neck squamous cell carcinoma cell lines with a new TRAIL soluble form, sfTRAIL

Matias Melendez
Molecular Oncology Research Center – Barretos Cancer Hospital, Brasil

Stage Classification of Non-small-cell Lung Carcinomas by Innovative Nanoparticle-protein corona Test

Marina Di Domenico
Dipartimento di Biochimica, Biofisica e Patologia Generale, Seconda Università degli Studi di Napoli, Italy

12:00 Lunch I Poster Viewing
13:00 Scientific Session C:                

Novel Findings and Updates in  Molecular Medicine

Nanomechanical Profiling as a Biomarker for Cancer

Jianyu Rao
Department of Pathology and Lab Med, UCLA, Los Angeles, CA, USA

Alphaherpesvirus Latency: Multidisciplinary Approach to Multisystem Disease

Randall J. Cohrs
Vice President, EUSTM, Denver, USA

ESE-1/Elf3 Mediates Cellular Transformation and its Overexpression Correlates with Poor Clinical Outcomes in HER2+ Luminal B Breast Cancer Patients

Arthur Gutierrez-Hartmann
University of Colorado, Anschutz Medical Campus, Denver, USA

Chair: Arthur Gutierrez-Hartmann
14:00 Scientific Session D:

Novel Findings and Updates in Disease Modelling

From animal model to translational strategy: A systematic review of experimental design in the preclinical and clinical studies of drugs for Rheumatoid Arthritis (RA)

Cathalijn Leenaars
Radboud university medical center, Nijmegen, Netherlands

Estimating the predictive validity of animal models of diabetes

Orsolya Varga
Department of Preventive Medicine, Faculty of Public Health, University of Debrecen, Debrecen, Hungary

From multistep carcinogenesis to the big bang: the translational relevance of cancer evolution models

Ulrich Pfeffer
San Martino Hospital, National Institute for Cancer Research Genoa & University of Genoa, Genova, Italy

Chair: Ulrich Pfeffer
15:00 Coffee Break I Poster Viewing
15:30

Scientific Session E: Translational Research: Novel Developments & Findings

Anti-inflammatory and anticancer activity of semisyntetic derivative of glycyrrhetinic acid Soloxolone methyl

Evgeniya LOGASHENKO
Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia

Translational research for clinical application of in vivo fluorescence imaging to hepatobiliary and pancreatic surgery

Takeaki Ishizawa
Cancer Institute Hospital, Japanese Foundation for Cancer Research & Graduate School of Medicine, The University of Tokyo,Tokyo, Japan

Chair: Ishizawa
16:30 Best Poster Awards Ceremony & Closing Remarks
Chair: Aamir Shahzad
17:30 Conference End

Post Congress Day: Thursday, 20 October 2016

10:30- 11:00
FAcadTM Qualifying Exam: Fellowship of the Academy of Translational Medicine Professionals

EUSTM Newsletter


(Latest News and Updates)


Congress Secretariat
Schwindgasse 4/7, 1040,
Vienna, Austria

+43 1 8923 562

+43 1 8923 562

2013-2016©European Society for Translational Medicine (EUSTM)

Translate »